Home
About
Overview
Sharing Data
ORCID
Help
History (14)
Triglyceride-lowering therapies reduce cardiovascular disease event risk in subjects with hypertriglyceridemia.
Suppression of the rbf null mutants by a de2f1 allele that lacks transactivation domain.
Flushing ASsessment Tool (FAST): psychometric properties of a new measure assessing flushing symptoms and clinical impact of niacin therapy.
Omega-3 free fatty acids for the treatment of severe hypertriglyceridemia: the EpanoVa fOr Lowering Very high triglyceridEs (EVOLVE) trial.
Raf kinase inhibitory protein: a signal transduction modulator and metastasis suppressor.
See All 14 Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Raf kinase inhibitory protein: a signal transduction modulator and metastasis suppressor.
Raf kinase inhibitory protein: a signal transduction modulator and metastasis suppressor. Cell Res. 2008 Apr; 18(4):452-7.
View in:
PubMed
subject areas
Animals
Humans
Mitosis
Neoplasm Metastasis
Phosphatidylethanolamine Binding Protein
raf Kinases
Signal Transduction
Tumor Suppressor Proteins
authors with profiles
Marsha Rosner